In patients with type 2 diabetes, fat distribution is characterized by visceral (VAT) and ectopic adipose tissues expansion, resulting in an increased interleukin 6 (IL-6) release and systemic low-grade inflammation. The gene discussed is IL6; the disease is type 2 diabetes mellitus.